Cite
HARVARD Citation
Coutadeur, S. et al. (n.d.). A novel DYRK1A (Dual specificity tyrosine phosphorylation‐regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro. Journal of neurochemistry. pp. 440-451. [Online].